P238: Enteropathy associated T-cell lymphoma as a diagnostic challenge in young patient with Crohn’s diseaseECCO'21 VirtualYear: 2021
Authors: Biscanin, A.(1);Tomasic, V.(1);Dorosulic, Z.(1);Kralj, D.(1);Lerotic, I.(1);Cacic, P.(1);Ogresta, D.(1);Hrabar, D.(1);
(1)University Hospital Centre Sestre Milosrdnice, Department of Internal Medicine, Zagreb, Croatia
P241: Gastrointestinal ultrasound instead of magnetic resonance enterography: Large potential cost savings with limited clinical downsidesECCO'21 VirtualYear: 2021
Authors: LuberMBBS Hons, R.(1);Petri, B.(1);Griffin, N.(2);Irving, P.(1);
(1)Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, United Kingdom;(2)Guy's and St Thomas' NHS Foundation Trust, Department of Radiology, London, United Kingdom
P242: Newly diagnosed Inflammatory Bowel Disease patients referred via the Straight To Test Lower GI two week wait pathway, Single Centre Study.ECCO'21 VirtualYear: 2021
Authors: Samarasinghe, M.(1);Chariah, F.(1);Desilva, C.(1);Koutsoumpas, A.(2);
(1)Barnet and Chase Farm Hospitals, Gastroenterology, London, United Kingdom;(2)Barnet and Chase Farm Hospitals, Department of Gastroenterology, London, United Kingdom
P243: Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers.ECCO'21 VirtualYear: 2021
Authors: Knyazev, O.(1,2,3);Kagramanova, A.(1);Lishchinskaya, A.(1);Li, I.(1);Noskova, K.(4);Fadeeva, N.(5);Subbotin, V.(1);Demchenko, A.(1);Babayan, A.(1);Zvyaglova, M.(1);Kulakov, D.(1,6);
(1)Moscow Scientific Center named after A. S. Loginov, Department of IBD, Moscow, Russian Federation;(2)State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Department of IBD, Moscow, Russian Federation;(3)Research Institute of Health Organization and Medical Management, Organization of Coloproctology, Moscow, Russian Federation;(4)Moscow Clinical Scientific Center named after A.S. Loginov, Department of Laboratory Diagnostics, Moscow, Russian Federation;(5)Moscow Clinical Scientific Center named after A.S. Loginov, Department of IBD, Moscow, Russian Federation;(6)Research Institute of Health Organization and Medical Management, Organization of Coloproctology, Moscow, Russian Federation
P244: Clinician preferences in treating steroid resistant ulcerative colitis: a discrete-choice experiment (DCE) surveyECCO'21 VirtualYear: 2021
Authors: Wickramasekera, N.(1);Shackley, P.(1);Coates, E.(1);Barr, A.(1);Lee, M.(2);Blackwell, S.(3);Bedford, H.(3);Dames, N.(3);Probert, C.(4);Sebastian, S.(5);Lobo, A.(2);
(1)University of Sheffield, School of health and related research, Sheffield, United Kingdom;(2)Sheffield Teaching Hospitals NHS Foundation Trust, Gastroenterology, Sheffield, United Kingdom;(3)Patient representative, Patient representative, Patient representative, United Kingdom;(4)University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom;(5)Hull University Teaching Hospitals NHS Foundation Trust, Gastroenterology, Hull, United Kingdom
P245: Evaluation of quality of life in patients with perineal Crohn’s disease: a monocentric Tunisien studyECCO'21 VirtualYear: 2021
Authors: Hamdi, S.(1);Ben Ameur, W.(1);Hammami, A.(1);Elleuch, N.(1);Dahmani, W.(1);Ben Slama, A.(1);Ksiaa, M.(1);Braham, A.(1);Ajmi, S.(1);Jaziri, H.(1);Jmaa, A.(1);
(1)Sahloul University Hospital, Gastroenterology, Sousse, Tunisia
P246: Development of a new Inflammatory Bowel Disease Patient Identifier shortens time to clinic review and initiation of treatmentECCO'21 VirtualYear: 2021
Authors: Chee, D.(1,2);Hamilton, B.(1,2);Cairnes, V.(2);Lin, S.(1,2);Chanchlani, N.(1,2);Ahmad, T.(1,2);Goodhand, J.(1,2);Kennedy, N.(1,2);
(1)IBD Pharmacogenetics Group, University of Exeter, Exeter, United Kingdom;(2)Royal Devon and Exeter NHS, Department of Gastroenterology, Exeter, United Kingdom
P247: Carotid Plaque Assessment reclassifies patients with Inflammatory Bowel Disease into Very-High Cardiovascular RiskECCO'21 VirtualYear: 2021
Authors: Hernandez Camba, A.(1);Carrillo-Palau, M.(2);Ramos, L.(2);Hernández Alvarez-Buylla, N.(2);Alonso-Abreu, I.(2);Hernández, A.(2);Vela, M.(1);Arranz, L.(1);Hernández-Guerra, M.(2);González-Gay, M.A.(3);Ferraz- Amaro, I.(4);
(1)Hospital Universitario de Nuestra Señora de la Candelaria, Gatroenterology, Santa Cruz de Tenerife, Spain;(2)Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain;(3)Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain;(4)Hospital Universitario de Canarias, Rheumatology, La Laguna, Spain
P249: What’s the role of anti-TNF α in correcting anemia in Crohn’s disease?ECCO'21 VirtualYear: 2021
Authors: Hassine, A.(1);Hammami, A.(1);Jaziri, H.(1);Elleuch, N.(1);Ksiaa, M.(1);Ben Slama, A.(1);Jmaa, A.(1);
(1)Hôpital universitaire Sahloul, service de gastro-entérologie, Sousse, Tunisia
P250: Does Ethnicity Influence Patient’s Preferences for Treatment Outcome? The Israeli ExperienceECCO'21 VirtualYear: 2021
Authors: Broide, E.(1);Richter, V.(1);Mari, A.(2); Khoury, T.(2); Shirin, H.(1);Naftali, T.(3);
(1)Shamir Medical Center, Gastroenterology, Tzerifin, Israel;(2)Nazareth Hospital, Gastroenterology, Nazareth, Israel;(3)Meir Medical Center, Gastroenterology, Kfar Saba, Israel
P251: Antiphospholipid antibodies in Crohn's disease: Results of a prospective single-center studyECCO'21 VirtualYear: 2021
Authors: Serghini, M.(1);Ben Youssef, H.(1);baccouche , H.(2);hafi, M.(1);labidy, A.(1);ben mustapha, N.(1);fekih, M.(1);boubaker, J.(1);
(1)La Rabta hospital, gastro-enterology department, tunis, Tunisia;(2)La Rabta hospital, Hematology Department, tunis, Tunisia
P252: Medication adherence in inflammatory bowel diseases in the era of biotherapiesECCO'21 VirtualYear: 2021
Authors: Hassine, A.(1);Hammami, A.(1);Ben Ameur, W.(1);Dahmani, W.(1);Elleuch, N.(1);Ben Slama, A.(1);Braham, A.(1);Ksiaa, M.(1);Bannour, R.(2);Jaziri, H.(1);Jmaa, A.(1);
(1)Hôpital universitaire Sahloul, service de gastro-entérologie, Sousse, Tunisia;(2)Hôpital universitaire Sahloul, service de sécurité des soins, Sousse, Tunisia
P253: A qualitative study exploring meaningful improvement in bowel urgency among adults with moderate to severe Ulcerative Colitis.ECCO'21 VirtualYear: 2021
Authors: Newton, L.(1);Guobyte, A.(2);McFadden, S.(2);Symonds, T.(1);Delbecque, L.(3);Donaldson , J.(4);Naegeli, A.(5);
(1)Clinical Outcomes Solutions, Clinical Outcomes Assessments, Folkstone, United Kingdom;(2)Clinical Outcomes Solutions, Clinical Outcomes Assessments, Chicago, United States;(3)Eli Lilly and Company, Patient Focused Outcomes, Brussels, Belgium;(4)Liberty University, Patient Expert, Linchburg, United States;(5)Eli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianpolis, United States
P254: Factors that may predict the need for infliximab optimization in Crohn's diseaseECCO'21 VirtualYear: 2021
Authors: Flores, C.(1);Petry, R.(2);Bortolin Fonseca, C.(2);Dos Santos Harlacher, L.(1);
(1)Instituto do Aparelho Digestivo, Crohn's and Colitis Reference Center, Porto Alegre, Brazil;(2)Universidade Federal do Rio Grande do Sul, Post-graduation in gastroenterology and hepatology, Porto Alegre, Brazil
P255: Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients.ECCO'21 VirtualYear: 2021
Authors: Crispino, F.(1);Grova, M.(1);Maida, M.(2);Renna, S.(3);Casà, A.(3);Rizzo, G.(3);Macaluso, F.S.(3);Orlando, A.(3);
(1)Department of Health Promotion Sciences Maternal and Infant Care- Section of Gastroenterology & Hepatology- Internal Medicine and Medical Specialties- PROMISE, University of Palermo, Palermo, Italy;(2)Section of Gastroenterology, 'S.Elia-Raimondi' Hospital, Caltanissetta, Italy;(3)Inflammatory Bowel Disease Unit, A.O.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
P256: High disease burden of CROHN'S DISEASE (CD) in a Latin American IBD reference centerECCO'21 VirtualYear: 2021
Authors: Sambuelli, A.(1);Gil , A.(1);Negreira , S.(1);Tirado , P.(1);Huernos, S.(1);Goncalves , S.(1);Lakatos , P.(2,3);
(1)IBD section - Bonorino Udaondo Hospital, Clinical Department, Buenos Aires, Argentina;(2)McGill University Health Centre- Montreal General Hospital, IBD Center, Montreal, Canada;(3)Semmelweis University, 1st Department of Medicine, Budapest, Hungary
